Purnanand D. Sarma - 28 May 2021 Form 4 Insider Report for Immunome Inc. (IMNM)

Role
president and CEO, Director
Signature
/s/ Purnanand D. Sarma
Issuer symbol
IMNM
Transactions as of
28 May 2021
Net transactions value
$0
Form type
4
Filing time
01 Jun 2021, 19:13:22 UTC
Previous filing
26 May 2021
Next filing
21 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMNM Stock Option (Right to Buy) Award $0 +93,354 $0.000000 93,354 28 May 2021 Common Stock 93,354 $20.92 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to the option vest on May 28, 2022, and one-thirty-sixth (1/36th) of the remaining shares subject to the option shall vest every month thereafter.